Atea Ebit vs Gross Profit Analysis
AVIR Stock | USD 3.72 0.00 0.00% |
Atea PharmaceuticalsI financial indicator trend analysis is way more than just evaluating Atea PharmaceuticalsInc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Atea PharmaceuticalsInc is a good investment. Please check the relationship between Atea PharmaceuticalsI Ebit and its Gross Profit accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
Ebit vs Gross Profit
Ebit vs Gross Profit Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Atea PharmaceuticalsInc Ebit account and Gross Profit. At this time, the significance of the direction appears to have strong relationship.
The correlation between Atea PharmaceuticalsI's Ebit and Gross Profit is 0.63. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Atea PharmaceuticalsInc, assuming nothing else is changed. The correlation between historical values of Atea PharmaceuticalsI's Ebit and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of Atea PharmaceuticalsInc are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Ebit i.e., Atea PharmaceuticalsI's Ebit and Gross Profit go up and down completely randomly.
Correlation Coefficient | 0.63 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Ebit
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Atea PharmaceuticalsInc minus its cost of goods sold. It is profit before Atea PharmaceuticalsI operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most indicators from Atea PharmaceuticalsI's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Atea PharmaceuticalsInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. As of 04/29/2024, Selling General Administrative is likely to drop to about 47.4 K. In addition to that, Tax Provision is likely to drop to about 967.1 K
2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 213K | 11.2M | 29.2M | 30.7M | Net Interest Income | 213K | 11.2M | 29.2M | 30.7M |
Atea PharmaceuticalsI fundamental ratios Correlations
Click cells to compare fundamentals
Atea PharmaceuticalsI Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Atea PharmaceuticalsI fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 22.1M | 863.6M | 772.9M | 666.7M | 595.0M | 541.8M | |
Other Current Liab | 1.9M | 14.4M | 52.3M | 15.2M | 27.4M | 20.6M | |
Total Current Liabilities | 2.4M | 315.8M | 56.9M | 18.5M | 32.4M | 57.0M | |
Total Stockholder Equity | (49.6M) | 547.8M | 710.1M | 640.6M | 555.2M | 434.1M | |
Other Liab | 95K | 36K | 5.9M | 5.3M | 6.0M | 6.3M | |
Net Tangible Assets | (49.6M) | 547.8M | 710.1M | 640.6M | 736.7M | 398.8M | |
Property Plant And Equipment Net | 41K | 48K | 23K | 4.1M | 3.1M | 3.3M | |
Net Debt | (21.7M) | (850.1M) | (764.2M) | (643.6M) | (141.4M) | (148.5M) | |
Retained Earnings | (54.2M) | (65.2M) | 56.0M | (59.9M) | (195.8M) | (186.0M) | |
Accounts Payable | 548K | 60K | 4.5M | 2.6M | 4.3M | 2.3M | |
Cash | 21.7M | 850.1M | 764.4M | 646.7M | 143.8M | 136.6M | |
Cash And Short Term Investments | 21.7M | 850.1M | 764.4M | 646.7M | 578.1M | 530.8M | |
Common Stock Shares Outstanding | 82.6M | 82.4M | 88.2M | 83.2M | 83.4M | 85.7M | |
Liabilities And Stockholders Equity | 22.1M | 863.6M | 772.9M | 666.7M | 595.0M | 541.8M | |
Non Current Liabilities Total | 69.2M | 36K | 5.9M | 7.7M | 7.4M | 7.0M | |
Other Current Assets | 249K | 7.5M | 8.0M | 14.2M | 12.3M | 7.8M | |
Other Stockholder Equity | 4.6M | 612.9M | 654.0M | 701.1M | 750.7M | 500.0M | |
Total Liab | 71.6M | 315.8M | 62.8M | 26.1M | 39.8M | 78.3M | |
Net Invested Capital | (49.6M) | 547.8M | 710.1M | 640.6M | 555.2M | 434.1M | |
Property Plant And Equipment Gross | 41K | 48K | 184K | 4.4M | 3.8M | 4.0M | |
Total Current Assets | 21.9M | 863.5M | 772.4M | 660.9M | 590.5M | 539.7M | |
Accumulated Other Comprehensive Income | (69.1M) | (863.6M) | 0.0 | (684K) | 207K | 217.4K | |
Net Working Capital | 19.5M | 547.7M | 715.5M | 642.4M | 558.1M | 461.3M | |
Property Plant Equipment | 41K | 48K | 23K | 4.1M | 4.7M | 4.9M |
Pair Trading with Atea PharmaceuticalsI
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atea PharmaceuticalsI position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea PharmaceuticalsI will appreciate offsetting losses from the drop in the long position's value.Moving against Atea Stock
0.69 | MMM | 3M Company Financial Report 23rd of July 2024 | PairCorr |
0.61 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
0.6 | GE | GE Aerospace Financial Report 23rd of July 2024 | PairCorr |
0.54 | BAC | Bank of America Sell-off Trend | PairCorr |
0.47 | CVX | Chevron Corp Financial Report 26th of July 2024 | PairCorr |
The ability to find closely correlated positions to Atea PharmaceuticalsI could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atea PharmaceuticalsI when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atea PharmaceuticalsI - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atea PharmaceuticalsInc to buy it.
The correlation of Atea PharmaceuticalsI is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atea PharmaceuticalsI moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atea PharmaceuticalsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atea PharmaceuticalsI can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Atea Stock analysis
When running Atea PharmaceuticalsI's price analysis, check to measure Atea PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea PharmaceuticalsI is operating at the current time. Most of Atea PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Atea PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Atea PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Transaction History View history of all your transactions and understand their impact on performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is Atea PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atea PharmaceuticalsI. If investors know Atea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atea PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.641 | Earnings Share (1.63) | Revenue Per Share 2.31 | Quarterly Revenue Growth 2.952 | Return On Assets (0.12) |
The market value of Atea PharmaceuticalsInc is measured differently than its book value, which is the value of Atea that is recorded on the company's balance sheet. Investors also form their own opinion of Atea PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Atea PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Atea PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Atea PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.